Clin Mol Hepatol.
2023 Jan;29(1):176-178. 10.3350/cmh.2022.0377.
Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Affiliations
-
- 1Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
- 2Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China
- 3School of Clinical Medicine, The University of Hong Kong, Hong Kong
- 4State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong
- KMID: 2538218
- DOI: http://doi.org/10.3350/cmh.2022.0377
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
- Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients: a single center study
- Different antibody responses between liver and kidney transplant recipients elicited by third doses of COVID-19 mRNA vaccines
- Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
